Legal Opinion
Sanofi v. Watson Laboratories Inc.
Court of Appeals for the Federal Circuit
Decided November 9, 2017No. 2016-2722, 2016-2726PublishedCited by 28 opinions
1Opinion of the Court
TARANTO, Circuit Judge.
Sanofi owns U.S. Patent Nos. 8,318,800 and 8,410,167, which describe and claim compositions and uses of the cardiovascular (specifically, antiarrhythmic) drug dro-nedarone. The ’800 patent, which expires in 2019, claims pharmaceutical compositions containing dronedarone. The ’167 patent, which expires in 2029, claims methods of reducing hospitalization by administering dronedarone to patients having specified characteristics. Sanofi’s subsidiary, Sanofi-Aventis U.S., LLC, received approval in mid-2009 for New Drug Application No. 022425 for 400 mg tablets of…
2Cases cited18 opinions
- Global-Tech Appliances, Inc. v. SEB S. A.Supreme Court of the United States · 2011
- Metro-Goldwyn-Mayer Studios Inc. v. Grokster, Ltd.Supreme Court of the United States · 2005
- Manville Sales Corporation, Plaintiff/cross-Appellant v. Paramount Systems, Inc., Robert S. Butterworth and Anthony J. DisimoneCourt of Appeals for the Federal Circuit · 1990
- Dsu Medical Corporation v. Jms Co., LtdCourt of Appeals for the Federal Circuit · 2006
- Commil United States, LLC v. Cisco Sys., Inc.Supreme Court of the United States · 2015
13 more not listed; retrieve them via the Exa API.
3Cited by28 opinions
- Tecsec, Inc. v. Adobe Inc.Court of Appeals for the Federal Circuit · 2020
- Vanda Pharmaceuticals Inc. v. West-Ward PharmaceuticalsCourt of Appeals for the Federal Circuit · 2018
- Barry v. Medtronic, Inc.Court of Appeals for the Federal Circuit · 2019
- BTG Int'l Ltd. v. Amneal Pharm. LLCDistrict Court, D. New Jersey · 2018
- H. Lundbeck A/S v. Lupin Ltd.Court of Appeals for the Federal Circuit · 2023
23 more not listed; retrieve them via the Exa API.